Publications by authors named "Amy Heimberger"

100Publications

Qki is an essential regulator of microglial phagocytosis in demyelination.

J Exp Med 2021 Jan;218(1)

Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20190348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7543092PMC
January 2021

Targeting the Tumor Microenvironment in Brain Metastasis.

Neurosurg Clin N Am 2020 Oct;31(4):641-649

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 422, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.nec.2020.06.011DOI Listing
October 2020

Ultrasound-induced blood-brain barrier disruption for the treatment of gliomas and other primary CNS tumors.

Cancer Lett 2020 Jun 27;479:13-22. Epub 2020 Feb 27.

Department of Neurosurgery, Sorbonne Université, UPMC Univ Paris 06, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpitaux Universitaires La Pitié-Salpêtrière, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2020.02.013DOI Listing
June 2020

Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.

J Neurooncol 2020 Feb 28. Epub 2020 Feb 28.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-020-03425-8DOI Listing
February 2020

Are radiation and response biomarkers the missing elements for efficacious immunotherapy for glioma patients?

Neuro Oncol 2020 05;22(5):590-591

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noaa018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229240PMC
May 2020

mutation spectrum in tumour types commonly diagnosed among -associated hereditary cancer syndrome families.

J Med Genet 2020 Oct 14;57(10):664-670. Epub 2020 Jan 14.

Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jmedgenet-2019-106657DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427478PMC
October 2020

Genetic and immune profiling for potential therapeutic targets in adult human craniopharyngioma.

Clin Oncol Res 2019 27;2(3):2-8. Epub 2019 Jun 27.

Departments of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.31487/j.COR.2019.03.05DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6844364PMC
June 2019

Shortened ex vivo manufacturing time of EGFRvIII-specific chimeric antigen receptor (CAR) T cells reduces immune exhaustion and enhances antiglioma therapeutic function.

J Neurooncol 2019 Dec 4;145(3):429-439. Epub 2019 Nov 4.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Unit 442, P.O. Box 301402, Houston, TX, 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03311-yDOI Listing
December 2019

Fibrinogen-like protein 2: a potential molecular target for glioblastoma treatment.

Expert Opin Ther Targets 2019 08 5;23(8):647-649. Epub 2019 Jun 5.

a Department of Neurosurgery , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2019.1628220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635074PMC
August 2019

Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD).

J Neurooncol 2019 May 7;142(3):499-509. Epub 2019 Mar 7.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-019-03121-2DOI Listing
May 2019

Steering CAR T cells to distinguish friend from foe.

Oncoimmunology 2019 6;8(10):e1271857. Epub 2018 Aug 6.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2016.1271857DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791456PMC
August 2018

Cell surface vimentin-targeted monoclonal antibody 86C increases sensitivity to temozolomide in glioma stem cells.

Cancer Lett 2018 10 6;433:176-185. Epub 2018 Jul 6.

Division of Pediatrics and Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canlet.2018.07.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6086585PMC
October 2018

Rethinking medulloblastoma from a targeted therapeutics perspective.

J Neurooncol 2018 Sep 5;139(3):713-720. Epub 2018 Jun 5.

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-018-2917-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132970PMC
September 2018

Comment on "Trivalent CAR T cells overcome interpatient antigenic variability in glioblastoma".

Neuro Oncol 2018 06;20(7):1003-1004

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/noy045DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007451PMC
June 2018

Identification of metabolites in plasma for predicting survival in glioblastoma.

Mol Carcinog 2018 08 16;57(8):1078-1084. Epub 2018 Apr 16.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22815DOI Listing
August 2018

Ependymomas overexpress chemoresistance and DNA repair-related proteins.

Oncotarget 2018 Jan 15;9(8):7822-7831. Epub 2017 Dec 15.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/23288
Publisher Site
http://dx.doi.org/10.18632/oncotarget.23288DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814261PMC
January 2018

Tumor image-derived texture features are associated with CD3 T-cell infiltration status in glioblastoma.

Oncotarget 2017 Nov 5;8(60):101244-101254. Epub 2017 Sep 5.

Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston 77030, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.20643DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731870PMC
November 2017

Serum HOTAIR and GAS5 levels as predictors of survival in patients with glioblastoma.

Mol Carcinog 2018 Jan 10;57(1):137-141. Epub 2017 Oct 10.

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mc.22739DOI Listing
January 2018

Immune Checkpoint Inhibitors for Brain Metastases.

Curr Oncol Rep 2017 Jun;19(6):38

Royal North Shore Hospital, St Leonards, NSW, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0596-3DOI Listing
June 2017

Tumor Vaccines for Malignant Gliomas.

Neurotherapeutics 2017 04;14(2):345-357

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13311-017-0522-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398993PMC
April 2017

Mutational burden, immune checkpoint expression, and mismatch repair in glioma: implications for immune checkpoint immunotherapy.

Neuro Oncol 2017 Aug;19(8):1047-1057

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas; Caris Life Sciences, Phoenix, Arizona; Departments of Biostatistics, Neuro-Pathology, Neuro-Oncology, Pediatrics, and Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nox026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570198PMC
August 2017

Immune Checkpoint Inhibitors in Gliomas.

Curr Oncol Rep 2017 Apr;19(4):23

NHMRC Clinical Trials Centre, University of Sydney, Locked Bag 77, Camperdown, NSW, 1450, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11912-017-0586-5DOI Listing
April 2017

Serum microRNA profiling in patients with glioblastoma: a survival analysis.

Mol Cancer 2017 03 11;16(1):59. Epub 2017 Mar 11.

Department of Neuro-Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12943-017-0628-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346242PMC
March 2017

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications.

Int Rev Immunol 2016 07 26;35(4):325-339. Epub 2014 Sep 26.

a Department of Pediatrics-Research , The University of Texas MD Anderson Cancer Center , Houston , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/08830185.2014.956360DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5257246PMC
July 2016

Interrogating Metabolism in Brain Cancer.

Magn Reson Imaging Clin N Am 2016 Nov;24(4):687-703

Department of Cancer Systems Imaging, MD Anderson Cancer Center, The University of Texas, Houston, TX, USA; The University of Texas Health Science Center at Houston, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mric.2016.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5091807PMC
November 2016

Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells.

Oncotarget 2016 Nov;7(44):72021-72032

Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.12458DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342141PMC
November 2016

MicroRNA-124 suppresses tumor cell proliferation and invasion by targeting CD164 signaling pathway in non-small cell lung cancer.

J Gene Ther 2016 Feb 13;2(1). Epub 2016 Feb 13.

Department of Thoracic & Cardiovascular Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927004PMC
http://dx.doi.org/10.13188/2381-3326.1000006DOI Listing
February 2016

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.

Neuro Oncol 2016 10 1;18(10):1357-66. Epub 2016 Jul 1.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.T.G., Y.H., A.B.H.); Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.-P.W., J.d.G.); Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (R.G.W.V.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (S.Z.); Department of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA (G.N.F.); Caris Life Sciences, Phoenix, Arizona, USA (J.X., Z.G., S.K.R., D.S.); The University of Sydney, Sydney, Australia (M.K.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/now132DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035527PMC
October 2016

miR-182-5p Induced by STAT3 Activation Promotes Glioma Tumorigenesis.

Cancer Res 2016 07 31;76(14):4293-304. Epub 2016 May 31.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-3073DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033679PMC
July 2016

Immunotherapy in glioblastoma: emerging options in precision medicine.

CNS Oncol 2016 07 26;5(3):175-86. Epub 2016 May 26.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cns-2016-0009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926530PMC
July 2016

Redirecting T-Cell Specificity to EGFR Using mRNA to Self-limit Expression of Chimeric Antigen Receptor.

J Immunother 2016 06;39(5):205-17

*Division of Pediatrics Departments of ‡Biostatistics ∥Neurosurgery §Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center †The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000126DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847343PMC
June 2016

Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?

Immunotherapy 2016 ;8(4):413-23

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Department of Neurosurgery, 1400 Holcombe Blvd, Unit 442, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.16.2DOI Listing
December 2016

Metabolomics profiling in plasma samples from glioma patients correlates with tumor phenotypes.

Oncotarget 2016 Apr;7(15):20486-95

Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.7974DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991469PMC
April 2016

Principles of immunotherapy.

Handb Clin Neurol 2016 ;134:163-81

Department of Neurosurgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/B978-0-12-802997-8.00010-4DOI Listing
December 2016

MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints.

Neuro Oncol 2016 05 11;18(5):639-48. Epub 2015 Dec 11.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas (J.W., E.K.N., L.-Y.K., Y.H., S.X., K.G., X.L., N.H., A.B.H.); Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.Q., S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas MD Anderson Cancer Center, Houston, Texas (C.I.); Departments of Neuropathology, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.N.F.); Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (M.R.G.); Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas (W.O.); Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas (G.A.C.); Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China (S.X.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov292DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827047PMC
May 2016

Immunosuppressive mechanisms in glioblastoma.

Neuro Oncol 2015 Nov;17 Suppl 7:vii9-vii14

Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., A.B.H.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nov151DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4625890PMC
November 2015

Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity.

Cancer Res 2015 Sep;75(17):3505-18

Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas. The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-15-0139DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624228PMC
September 2015

PD-L1 expression and prognostic impact in glioblastoma.

Neuro Oncol 2016 Feb 30;18(2):195-205. Epub 2015 Aug 30.

Departments of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (E.K.N., J.W., N.K.Y., N.H., L.-Y.K., K.G., X.L., A.B.H.); Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (S.Z.); Center for RNA Interference and Non-Coding RNAs, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.I.); Flow Cytometry and Cell Imaging Core Facility, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.K.B.); Neuropathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.N.F.); Department of Experimental Therapeutics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (G.A.C.); Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.A.C.); Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas (C.C., K.R.); Lion Biotechnologies, Woodland Hills, California (J.Q.C., L.R.); Dept. of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida (J.Q.C., L.R.).

View Article

Download full-text PDF

Source
http://neuro-oncology.oxfordjournals.org/content/early/2015/
Web Search
http://neuro-oncology.oxfordjournals.org/lookup/doi/10.1093/
Publisher Site
http://dx.doi.org/10.1093/neuonc/nov172DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724183PMC
February 2016

FGL2 as a Multimodality Regulator of Tumor-Mediated Immune Suppression and Therapeutic Target in Gliomas.

J Natl Cancer Inst 2015 Aug 13;107(8). Epub 2015 May 13.

Department of Pediatric Research (JY, JH, DD, XX, SL) and Department of Neurosurgery (LYK, KG, ABH), The University of Texas M.D. Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554195PMC
August 2015

FoxM1 Drives a Feed-Forward STAT3-Activation Signaling Loop That Promotes the Self-Renewal and Tumorigenicity of Glioblastoma Stem-like Cells.

Cancer Res 2015 Jun 1;75(11):2337-48. Epub 2015 Apr 1.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-14-2800DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4452436PMC
June 2015

The role of STAT3 in tumor-mediated immune suppression.

J Neurooncol 2015 Jul 22;123(3):385-94. Epub 2015 Feb 22.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX, 77030, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-015-1731-3DOI Listing
July 2015

A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

Neuro Oncol 2015 Jun 13;17(6):854-61. Epub 2015 Jan 13.

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania (J.S.); The Neurological Institute of Columbia University, New York, New York (R.K.L.); Stanford Cancer Center, Stanford, California (L.D.R.); Duke University Medical Center, Durham, North Carolina (D.A.R., G.E.A., D.D.B., J.H.S.); Evanston Northwestern Healthcare, Evanston, Illinois (N.A.P.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (M.D.G.); University of Washington School of Medicine, Seattle, Washington (M.M.M.); Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah (R.J.); Yale University School of Medicine, New Haven, Connecticut (J.M.B); University Hospital-Case Medical Center & Case Comprehensive Cancer Center, Cleveland, Ohio (A.S.); Scott Cruickshank & Associates, Inc., Santa Barbara, C alifornia (S.C.); Celldex Therapeutics, Inc., Hampton, New Jersey (J.A.G., T.K., T.A.D.); University of Texas M.D. Anderson Cancer Center, Houston, Texas (A.B.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4483122PMC
June 2015

Therapeutic targets in subependymoma.

J Neuroimmunol 2014 Dec 31;277(1-2):168-75. Epub 2014 Oct 31.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2014.10.008DOI Listing
December 2014

Immunotherapy for primary brain tumors: no longer a matter of privilege.

Clin Cancer Res 2014 Nov;20(22):5620-9

Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0832DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235630PMC
November 2014

Epidermal growth factor receptor and variant III targeted immunotherapy.

Neuro Oncol 2014 Oct;16 Suppl 8:viii20-5

The Preston Robert Tisch Brain Tumor Center (K.L.C., P.C.G., C.M.S., J.H.S.); Division of Neurosurgery, Department of Surgery, Duke University Medical Center Durham, North Carolina (K.L.C., P.C.G., C.M.S., J.H.S.); Department of Biomedical Engineering, Duke University Durham, North Carolina (P.C.G.); Department of Pathology, Duke University Medical Center Durham, North Carolina (J.H.S.); Department of Immunology, The University of Texas M.D. Anderson Cancer Center Houston, Texas (H.G.C., L.J.N.C.); Division of Pediatrics, The University of Texas M.D. Anderson Cancer Center Houston, Texas (H.G.C., L.J.N.C.); Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center Houston, Texas (A.B.H.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nou236DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207138PMC
October 2014

Effect of miR-142-3p on the M2 macrophage and therapeutic efficacy against murine glioblastoma.

J Natl Cancer Inst 2014 Aug 28;106(8). Epub 2014 Jun 28.

Affiliations of authors: Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan, China (SX, X-GL), Department of Neurosurgery (SX, JW, FW, L-YK, X-YL, EN, KG, TD, YY, FFL, GR, ABH), Department of Biostatistics (WQ), Department of Pathology (GNF), and Department of Experimental Therapeutics (GAC), University of Texas M. D. Anderson Cancer Center, Houston, TX; Baylor College of Medicine, Houston, TX (NKY); Texas A&M University College of Veterinary Medicine & Biomedical Sciences, College Station, TX (VF).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271080PMC
August 2014

Targeting 4-1BB costimulation to the tumor stroma with bispecific aptamer conjugates enhances the therapeutic index of tumor immunotherapy.

Cancer Immunol Res 2014 Sep 17;2(9):867-77. Epub 2014 Jun 17.

Department of Microbiology and Immunology, Dodson Interdisciplinary Immunotherapy Institute, Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-14-0007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502823PMC
September 2014

Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas.

Cancer Immunol Res 2013 Aug;1(2):112-22

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, 77030.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-13-0028DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3881271PMC
August 2013

MicroRNAs as novel immunotherapeutics.

Oncoimmunology 2013 Aug 28;2(8):e25124. Epub 2013 May 28.

Department of Neurosurgery; The University of Texas M.D. Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.25124DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782519PMC
August 2013

The controversial role of microglia in malignant gliomas.

Clin Dev Immunol 2013 24;2013:285246. Epub 2013 Jul 24.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/285246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741958PMC
February 2014

BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.

Cancer Immunol Immunother 2013 Jun 17;62(6):983-7. Epub 2013 Apr 17.

Duke Brain Tumor Immunotherapy Program, Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-013-1405-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665719PMC
June 2013

miRNA-mediated immune regulation and immunotherapeutic potential in glioblastoma.

Clin Investig (Lond) 2011 Dec;1(12):1637-1650

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4155/cli.11.159DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314429PMC
December 2011

Consensus on the role of human cytomegalovirus in glioblastoma.

Neuro Oncol 2012 Mar 8;14(3):246-55. Epub 2012 Feb 8.

Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, 1400 Holcombe Blvd., Unit 442, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nor227DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280809PMC
March 2012

The therapeutic potential of inhibitors of the signal transducer and activator of transcription 3 for central nervous system malignancies.

Authors:
Amy B Heimberger

Surg Neurol Int 2011 14;2:163. Epub 2011 Nov 14.

Department of Neurosurgery, The University of Texas M. D. Anderson Cancer Center, Unit 442, 1515 Holcombe Boulevard, Houston TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/2152-7806.89886DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3228387PMC
October 2012

Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group.

Neurosurgery 2012 Jan;70(1):234-43; discussion 243-4

Brain Tumor and Neuro-Oncology Center, Department of Neurosurgery, Cleveland Clinic, Cleveland, Ohio 44195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1227/NEU.0b013e318223f5a7DOI Listing
January 2012